Ha kapcsolatba szeretne lépni a Tudóstér adminisztrátoraival, kérjük töltse ki az alábbi űrlapot, vagy küldjön e-mailt a publikacioklib.unideb.hu címre.
Bejelentkezés
A Tudóstér funkcióinak nagy része bejelentkezés nélkül is elérhető. Bejelentkezésre az alábbi műveletekhez van szükség:
Vleugels, R. A.,
Paik, J. J.,
Bauer Ventura, I.,
Mangold, A. R.,
Gandiga, P. C.,
Haemel, A.,
Chinoy, H.,
Hussain, Y. M.,
Sivakumar, K.,
Griger, Z.,
Lee, E. B.,
Bozán, F.,
Hsu, C. Y.,
Femia, A.,
Dimachkie, M. M.,
Min, M. S.,
Mozaffar, T.,
Charles-Schoeman, C.,
Fernandez, D. R.,
Onajin, O.,
Campanilho-Marques, R.,
Marder, G.,
Ernste, F.,
Schiopu, E.,
Sluzevich, J.,
Pearson, D.,
Lindsey, S.,
Luggen, M.,
Bubb, M. R.,
Boh, E.,
Maganti, R.,
Heinlen, L.,
Shaw, K. S.,
Cascino, M. D.,
Mudd, P. N.,
Vencovsky, J.,
Fernandez, A. P.,
Fiorentino, D.,
Christopher-Stine, L.,
Werth, V. P.,
Aggarwal, R.,
VALOR Investigators:
A Phase 3 Trial of Brepocitinib in Dermatomyositis.
N. Engl. J. Med. 394 (19), 1883-1893, 2026.
Agmon-Levin, N.,
Ignatenko, S.,
Gordienko, A.,
Cortés-Hernández, J.,
Narongroeknawin, P.,
Romanowska-Próchnicka, K.,
Shen, N.,
Ciferská, H.,
Kodera, M.,
Cheng-Chung, W. J.,
Leszczyński, P.,
Lan, J. L.,
Mysler, E.,
Wojciechowski, R.,
Tarr, T.,
Vishneva, E.,
Chen, Y. H.,
Kaneko, Y.,
Finzel, S.,
Hoi, A.,
Okada, M.,
Koolvisoot, A.,
Lee, S. S.,
Lie, D.,
Kaneko, H.,
Rojkovich, B.,
Sun, L.,
Zotkin, E.,
Viallard, J. F.,
López, B. P. M.,
Ghanshani, S. A.,
Lau, C.,
Avrameas, A.,
Sips, C.,
Oliver, S. J.:
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment.
Ann. Rheum. Dis. 85 (3), 476-488, 2026.
Balogh, L.,
Szklenár, E.,
Diós, Á.,
Arany, A. C.,
Pucsok, J. M.,
Bács, Z. M.,
Rátgéber, L.,
Csiki, Z.,
Gyetvai, Á.,
Papp, G.:
The Acute Effects of High-Intensity Interval Training on Oxidative Stress Markers and Phagocyte Oxidative Burst Activity in Young Professional Athletes and Non-Athlete University Students.
Life. 16 (1), 1-13, (cikkazonosító: 84), 2026.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
(2025)
Q1
Ecology, Evolution, Behavior and Systematics
(2025)
Q1
Paleontology
(2025)
Q2
Space and Planetary Science
(2025)
2025
7.
Ramos-Casals, M.,
Baer, A. N.,
Brito-Zerón, P.,
Hammitt, K. M.,
Bouillot, C.,
Retamozo, S.,
Mackey, A.,
Yarowsky, D.,
Turner, B.,
Blanck, J.,
Fisher, B.,
Akpek, E. K.,
Baldini, C.,
Bootsma, H.,
Bowman, S. J.,
Dörner, T.,
Laing, L.,
Lieberman, S. M.,
Mariette, X.,
Pflugfelder, S. C.,
Sankar, V.,
Sisó-Almirall, A.,
Tzioufas, A. G.,
Anaya, J. M.,
Armagan, B.,
Bombardieri, M.,
Carsons, S. E.,
Vita, S. d.,
Fox, R. I.,
Gerli, R.,
Giacomelli, R.,
Gottenberg, J. E.,
Hernandez-Molina, G.,
Jonsson, R.,
Kruize, A. A.,
Kwok, S. K.,
Li, X.,
McCoy, S. S.,
Ng, W. F.,
Olsson, P.,
Rischmueller, M.,
Saraux, A.,
Scofield, R. H.,
Valim, V.,
Vitali, C.,
Vivino, F.,
Wahren-Herlenius, M.,
Moutsopoulos, H. M.,
International Task Force on Nomenclature of Sjögren Disease:
2023 International Rome consensus for the nomenclature of Sjögren disease.
Nat. Rev. Rheumatol. 21 (7), 426-437, 2025.
Aradi, Z.,
Bói, B.,
Nagy, G.,
Antal-Szalmás, P.,
Mezei, K.,
Horváth, I. F.,
Szántó, A.:
Additive Value of Rheumatoid Factor Isotypes in Sjögren's Syndrome Patients with Joint Complaints of Different Etiologies: Can Rheumatoid Factor IgA Serve as an Early, Poor Prognostic Biomarker Candidate?.
Int. J. Mol. Sci. 26 (10), 1-13, (cikkazonosító: 4797), 2025.
Gono, T.,
Gil-Vila, A.,
Selva-O'Callaghan, A.,
van Royen-Kerkhof, A.,
Vincze, A.,
Mecoli, C.,
Gómez-Martin, D.,
Hamann, D.,
Conticini, E.,
Griger, Z.,
Torres-Ruiz, J.,
Pauling, J. D.,
Chinoy, H.,
Gupta, L.,
Bodoki, L.,
Nasir, N.,
Chavan, P. P.,
Khubchandani, R.,
Ernesto, T. A.,
Hamaguchi, Y.,
Rider, L. G.,
Aggarwal, R.,
Tansley, S.,
Rönnelid, J.,
Kuwana, M.,
McHugh, N.,
International Myositis Assessment and Clinical Studies Group,
Myositis Autoantibody Scientific Interest Group (SIG) Study:
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: a systematic review and meta-analysis.
Semin. Arthritis Rheum. 75, 1-11, (cikkazonosító: 152858), 2025.
Nagy, E. B.,
Majai, G.:
Az MR szerepe a tüdőbetegségek diagnosztikájában, különös tekintettel az intersticiális tüdőbetegségre.
Med. Tribune. 23 (5), 16-17, 2025.
Horváth, I. F.:
Az osteoarthritis pathomechanizmusának új aspektusai, időskori kezelése az új szakmai ajánlások tükrében.
Idősgyógy. 10 (1-2), 5-10, 2025.
Hoff, L. S.,
Ravichandran, N.,
Sen, P.,
Day, J.,
Joshi, M.,
Nune, A.,
Nikiphorou, E.,
Saha, S.,
Tan, A. L.,
Shinjo, S. K.,
Ziade, N.,
Velikova, T.,
Milchert, M.,
Jagtap, K.,
Parodis, I.,
Gracia-Ramos, A. E.,
Cavagna, L.,
Kuwana, M.,
Knitza, J.,
Chen, Y. M.,
Makol, A.,
Agarwal, V.,
Patel, A.,
Pauling, J. D.,
Wincup, C.,
Barman, B.,
Tehozol, E. A. Z.,
Serrano, J. R.,
Torre, I. G. D. l.,
Colunga-Pedraza, I. J.,
Merayo-Chalico, J.,
Chibuzo, O. C.,
Katchamart, W.,
Akawatcharangura Goo, P.,
Shumnalieva, R.,
El Kibbi, L.,
Halabi, H.,
Vaidya, B.,
Shaharir, S. S.,
Hasan, A. T. M. T.,
Dey, D.,
Gutiérrez, C. E. T.,
Caballero-Uribe, C. V.,
Lilleker, J. B.,
Salim, B.,
Gheita, T. A.,
Chatterjee, T.,
Distler, O.,
Saavedra, M. A.,
Chinoy, H.,
Agarwal, V.,
Aggarwal, R.,
Gupta, L.,
COVAD Study Group:
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study.
RHEUMATOLOGY. 64 (2), 597-606, 2025.
Ali, S. S.,
Demetriou, C.,
Parodis, I.,
Tan, A. L.,
Edgar Gracia-Ramos, A.,
Joshi, M.,
Caballero-Uribe, C. V.,
Saha, S.,
Lilleker, J. B.,
Nune, A.,
Pauling, J. D.,
Wincup, C.,
Jagtap, K.,
Dey, D.,
Milchert, M.,
Distler, O.,
Chinoy, H.,
Agarwal, V.,
Gupta, L.,
Nikiphorou, E.,
COVAD Study Group:
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study.
Rheumatol. Adv. Pract. 9 (1), 1-10, (cikkazonosító: 154), 2025.
Venerito, V.,
Del Vescovo, S.,
Prieto-González, S.,
Fornaro, M.,
Cavagna, L.,
Iannone, F.,
Kuwana, M.,
Agarwal, V.,
Day, J.,
Joshi, M.,
Saha, S.,
Jagtap, K.,
Katchamart, W.,
Akawatcharangura Goo, P.,
Vaidya, B.,
Velikova, T.,
Sen, P.,
Shinjo, S. K.,
Tan, A. L.,
Ziade, N.,
Milchert, M.,
Edgar Gracia-Ramos, A.,
Caballero-Uribe, C. V.,
Chinoy, H.,
Gupta, L.,
Agarwal, V.,
COVAD Study Group:
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.
Rheumatol. Adv. Pract. 9 (2), 1-9, (cikkazonosító: 031), 2025.
Aggarwal, R.,
Schessl, J.,
Bata-Csörgő, Z.,
Dimachkie, M. M.,
Griger, Z.,
Moiseev, S.,
Oddis, C. V.,
Schiopu, E.,
Vencovsky, J.,
Clodi, E.,
Levine, T.,
Charles-Schoeman, C.,
ProDERM Trial Group:
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: sub-analysis of the ProDERM Study.
Rheumatol. Ther. 12 (5), 855-871, 2025.
Tóthfalusi, D.,
Gulyás, A.,
Koncz, A.,
Zöld, É.,
Illés, Á.,
Miltényi, Z.:
Hodgkin Lymphoma Associated with Common Variable Immunodeficiency: the Role of Early Diagnosis and Multidisciplinary Management.
Hematol Rep. 17 (6), 1-15, (cikkazonosító: 65), 2025.
Delgado, L.,
Flores-Chávez, A.,
Szántó, A.,
Priori, R.,
Bootsma, H.,
Armagan, B.,
Quartuccio, L.,
Praprotnik, S.,
Suzuki, Y.,
Hernandez-Molina, G.,
Romão, V. C.,
Sebastian, A.,
Bartoloni, E.,
Rischmueller, M.,
Solans, R.,
Pasoto, S.,
Fugmann, C.,
Sánchez Berná, I.,
Carubbi, F.,
Fernandes Moça Trevisani, V.,
Valim, V.,
Melchor, S.,
Maure, B.,
Fonseca-Aizpuru, E.,
Nakamura, H.,
López-Dupla, M.,
Vázquez, M.,
Akasbi, M.,
Policarpo Torres, G.,
De Miguel Campo, B.,
Suru, M. R.,
Vericat Queralt, C.,
Horváth, I. F.,
Fischetti, I.,
Vissink, A.,
Kilic, L.,
Manfre, V.,
Perdan Pirkmajer, K.,
Fujisawa, Y.,
Bandeira, M.,
Proc, K.,
Gerli, R.,
Kirana, C.,
Nardi, N.,
Ramos-Casals, M.,
Brito-Zerón, P.,
Sjögren Big Data Consortium:
Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis.
Clin. Exp. Rheumatol. 43 (12), 2124-2132, 2025.
